Cargando…
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
BACKGROUND: Debate continues as to whether acute bronchodilator responsiveness (BDR) predicts long-term outcomes in COPD. Furthermore, there is no consensus on a threshold for BDR. METHODS: At baseline and during the 4-year Understanding Potential Long-term Improvements in Function with Tiotropium (...
Autores principales: | Hanania, Nicola A, Sharafkhaneh, Amir, Celli, Bartolome, Decramer, Marc, Lystig, Ted, Kesten, Steven, Tashkin, Donald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027109/ https://www.ncbi.nlm.nih.gov/pubmed/21219660 http://dx.doi.org/10.1186/1465-9921-12-6 |
Ejemplares similares
-
Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011) -
Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011) -
Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012) -
Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial
por: Celli, Bartolomé R., et al.
Publicado: (2016) -
Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)